Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences
BEDFORD, Mass. , Nov. 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company ...